Iron deficiency and anaemia in people with inflammatory bowel disease: do we have an ongoing issue of care quality? Crohns Colitis Cure data insights programme
Despite being a well-known issue in IBD, easily diagnosed and treated, ID remains highly prevalent in routine care in this large real-world cohort. ID is more common than ID with anaemia, yet both likely impair quality of life. Protocolised screening and repletion may be needed to ensure consistency, and approaches such as benchmarking or open data reporting on key performance indicators may need to be implemented to drive change at scale.
Authors
- W.J. Wilson (ORCID: https://orcid.org/0000-0001-5658-0997)
- Jane M. Andrews (ORCID: https://orcid.org/0000-0001-7960-2650)
- Susan J. Connor (ORCID: https://orcid.org/0000-0001-5606-0270)
- Wai Kin Su (ORCID: https://orcid.org/0000-0001-6556-6708)
- Brigid Pinnuck (ORCID: https://orcid.org/0009-0007-5119-3112)
Institutions
- Royal Adelaide Hospital (AU)
- Lyell McEwin Hospital (AU)
- UNSW Sydney (AU)
- Eastern Health (AU)
- Crohn's & Colitis Australia (AU)
- Ingham Institute (AU)
- South Western Sydney Local Health District (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1111/imj.70282
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb